Neoplasms study on dbGaP (222 participants)

phs001952 — National Cancer Institute (NCI) Early Onset Malignancies Initiative    (EOMI): Molecular profiling of Breast, Colon, Kidney, Liver, Multiple    Myeloma, and Prostate among Racially and Ethnically Diverse    Populations

<p>The Early Onset Malignancies Initiative (EOMI) is focused on collecting specimens from racially and ethnically diverse population groups with six different types of cancer (breast, prostate, colon, liver, kidney, and multiple myeloma). This initiative is a partnership between the Center for Research Strategy, the Center for Cancer Genomics and the Division of Cancer (DCP). DCP's NCI Community Oncology Research Program (NCORP) is a critical partner. The acquisition of the cancer and matching normal biospecimens in this initiative are from newly diagnosed early onset cancer patients who identify as Non-Hispanic Black, Hispanic, American Indian or Alaska Native, or Non-Hispanic White. The Minority/Underserved NCORPs sites will collect the samples for this project. By carrying out this initiative in the NCORP's national network of investigators, cancer care providers, and research institutions, the EOMI will harness the community-based partnerships to improve participation among these racial/ethnic groups.</p> <p>The NCORP investigators, as participants in NCI's clinical trials network, will annotate the biologic samples with clinical information that will enhance the ability to answer questions about molecular determinants of early disease, treatment response, and/or prognosis. The EOMI will be a step forward in addressing racial/ethnic disparities and in understanding cancer in underserved populations. </p>

National Cancer Institute (NCI) Early Onset Malignancies Initiative    (EOMI): Molecular profiling of Breast, Colon, Kidney, Liver, Multiple    Myeloma, and Prostate among Racially and Ethnically Diverse    Populations